Evidence map›Paper›PMID 30274476›Full record

ReviewTropical medicine and infectious disease2018

New Immuno-Epidemiological Biomarker of Human Exposure to Aedes Vector Bites: From Concept to Applications.

André B Sagna, Mabo C Yobo, Emmanuel Elanga Ndille, Franck Remoue

Abstract readReview
In one paragraph

Review in Tropical medicine and infectious disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. IgG Antibody Responses to theFrontiers in cellular and infection microbiology · 2020
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

André B SagnaMIVEGEC, IRD, CNRS, Univ. Montpellier, BP 64501, 34394 Montpellier, France. andre.sagna@ird.fr.
Mabo C YoboInstitut Pierre Richet (IPR), Institut Nationale de la Santé Publique (INSP), BP 1500 Bouaké, Côte d'Ivoire.
Emmanuel Elanga NdilleMIVEGEC, IRD, CNRS, Univ. Montpellier, BP 64501, 34394 Montpellier, France. emmsdille@yahoo.fr.
Franck RemoueMIVEGEC, IRD, CNRS, Univ. Montpellier, BP 64501, 34394 Montpellier, France. franck.remoue@ird.fr.ORCID 0000-0003-3220-5660

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arthropod-borne viruses (arboviruses) such as dengue virus (DENV), chikungunya virus (CHIKV), Zika virus (ZIKV), and yellow fever virus (YFV) are the most important 'emerging pathogens' because of their geographic spread and their increasing impact on vulnerable human populations. To fight against these arboviruses, vector control strategies (VCS) remain one of the most valuable means. However, their implementation and monitoring are labour intensive and difficult to sustain on large scales, especially when transmission and

Indexed as

Aedes exposurearbovirus transmissionbiomarkerimmuno-epidemiologysalivary proteins

Identifiers

PMID30274476
PMCPMC6161005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.